Sentences with phrase «cell products»

In addition to its emphasis on producing vaccines, the lab specializes in gene and cell therapies, including stem cell products.

Industry developers, in general, favor so - called centralized model of cell product manufacturing / delivery.

Check out a video of this and another interesting portable hydrogen fuel cell product.

To that end, he said, Juno intends next year to launch a trial with a defined cell product candidate in adult ALL.

Osiris (Nasdaq: OSIR, US) Osiris is trying very hard to enter the market with a first off - the - shelf mesenchymal stem cell product in US.

Based on these advances in stem cell technology, Novocell has begun a development program to prepare its stem cell products for human clinical therapy.

«As a result of the timing delay that would entail and Juno's belief that it has other product candidates in its pipeline that are likely to provide improved efficacy and tolerability, Juno, in collaboration with partner Celgene, has made a strategic decision to cease development of JCAR015 at this time and to redirect associated resources to the development of a defined cell product candidate in the adult r / r ALL setting,» Juno added.

New Haven, CT About Blog This blog covers such topics as cell therapy, regenerative medicine, gene therapy, clinical trials in medicine, cell transplantation, cell products manufacturing, cell therapy regulation, stem cell research, immunology, bone marrow transplantation, evidence - based medicine.

This has been attributed to both genetic deficiency and immune cell products that prevent production of filaggrin.

Longevity of cells could be linked to levels of cellular pumps that get rid of toxic cell products.

In fact, in an ongoing clinical trial that is transplanting cells derived from induced pluripotent stem cells (iPSCs), gene sequencing is used to ensure the transplanted cell products are free of dangerous mutations.

«We think this could be a significant step toward a variety of commercially available perovskite cell products,» Padture said.

His laboratory (The Laboratory for Cell and Gene Medicine) specializes in the development of manufacturing processes and QC assays and provides cGMP compliant clinical materials production and regulatory support activities for investigational cell products.

For cell therapy, automation can be used to increase the scale of cell culture operations (e.g., bioreactors replacing flasks) and allow the use of closed systems that can protect cell products from contamination with adventitious agents from the environment or operators themselves.

These animal - sourced components significantly limit the application of EB formation to generate potentially clinically relevant cell products.

The use of autologous cell products in «non-homologous» applications will require full FDA approval.

«Novocell is a leader in differentiation of stem cells to create functional islet cells of the pancreas, and this broad patent significantly enhances our proprietary position and further secures our investment in the development of a diabetes cell therapy and potentially other endoderm - derived cell products,» said Edward Baetge, Ph.D., Senior Vice President and Chief Scientific Officer of Novocell.

For patients this translates to insufficient safety standards, zero facility inspection and no oversight of the resultant cell product (s) for purity and viability.

It seems all the Juicy Organic Stem Cell products provide a natural lightener when applied.

At the National Cancer Institute in Bethesda, Maryland, hematologist James Kochenderfer's waiting list is driven by the two or three CAR - T cell products a month he's able to secure from the agency's facility.

NREL's strength in technology validation and lifecycle analysis on fuel cell products can be leveraged to study lifecycle of the hydrogen production component and system.

Juno has also said that the clinical hold on the ROCKET trial would not affect plans for its other CD19 - directed CAR T - cell product candidates, including JCAR017, for which the company anticipates a 2018 approval.

FDA's position on assessment of tumorigenic potential of cell products for regenerative medicine

In addition to an innovative method for cell purification, scientists also have at their disposal a new TUM facility for the sterile manufacture of cell products.

«Clearly, there has been increased international focus on what is going on in the Korean regenerative industry since the approval of three stem - cell products in the past year, which I think caught many industry observers off guard,» says Douglas Sipp, who works on stem - cell policy and ethics at the RIKEN Center for Developmental Biology in Kobe, Japan.

At this time, trials and plans for its other CD19 - directed chimeric antigen receptor (CAR) T - cell product candidates, including JCAR017, are not affected.

Juno asserted that the clinical hold on the ROCKET trial did not affect plans for its other CD19 - directed CAR T - cell product candidates, including JCAR017, for which the company has launched two clinical trials now recruiting patients.

Dozens of trials are underway, and two CAR - T cell products, for childhood and young adult ALL and aggressive B - cell lymphoma, may be approved later this year by the U.S. Food and Drug Administration (FDA).

Cell products are released into the tissue, and organs of an organism, to finally affect the physiology in a way that produces a trait.

«From a bioprocessing standpoint, a lot of the cost involved in making stem cell products is related to the cost of the molecules that must be added to make the stem cells differentiate.»

Fuel cell products are already used widely in warehouses, and this project broadens their reach.»

Under his direction, plasmid DNA, CAR - T - cells, regulatory T - cells, engineered stem cell grafts and gene modified hematopoietic stem cell products have been manufactured and released for use in Phase I / II clinical trials.

Hermann pointed out, one particular red flag to look out for is multiple conditions being treated with exactly the same stem cell product.

It will be very interesting to watch how well allogeneic «off - the - shelf» stem cell product will be doing on the regional market.

In summary, a number of promising stem cell products are currently tested in clinics in attempt to repopulate the infarcted myocardium and bring a solution to the patients suffering from the damage to the cardiac tissue.

NeuroStemcell recognizes the essential requirement to include a coherent program of both internal and open activities to promote training and networking within the consortium while maximizing synergy and interaction, and to develop the level of exchange, understanding and awareness necessary to create a critical mass of trained researchers and clinical scientists across Europe able to help the assessment of the clinical value of selected stem cell products.

Although regulatory precedents have been set for various autologous and allogeneic products in the United States, Asia, and the European Union, regulatory guidance continues to evolve for a widening array of cell products.

R&D Systems has since established itself as a developer and manufacturer of high - quality proteins and the world leader in immunoassays as well as a producer of antibodies, arrays, stem cell products, cell selection and detection products among other cell biology tools.

The choice of the somatic cell for reprogramming, the reprogramming technology chosen, and the differentiation techniques utilised, all work synergistically towards the production of mature iPSCs - derived chondrocytes which are comparable to patient - derived chondrocytes, in line with Good Manufacturing Practice guidelines for an «off - the - shelf» stem cell product.

Unique research resources include synthetic compounds, model organisms, cell lines, viruses, cell products, and cloned DNA, as well as DNA sequences, mapping information, crystallographic coordinates, and spectroscopic data.

Right now, stem cell products are commonly produced on a very small scale to use in lab experiments, but we need to make them in much greater orders of magnitude for use in future human therapies.

At BioGenix we are seeking a qualified Medical Sales Rep who will be responsible for presenting and selling our stem cell product to new and existing customers to drive company revenue and that has...